Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
---|
09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
09/12/2002 | CA2438737A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists |
09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
09/12/2002 | CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
09/11/2002 | EP1239032A1 Lactic acid bacteria as agents for treating and preventing allergy |
09/11/2002 | EP1238669A2 Neutrophil function inhibitors which contain glucosamine |
09/11/2002 | EP1238082A2 Ifn-alpha homologues |
09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
09/11/2002 | EP1238070A2 Therapeutically useful synthetic oligonucleotides |
09/11/2002 | EP1238016A1 Substituted phthalocyanines and their precursors |
09/11/2002 | EP1237902A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
09/11/2002 | EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators |
09/11/2002 | EP1237878A2 4-pyrimidinyl-n-acyl-l-phenylalanines |
09/11/2002 | EP1237876A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
09/11/2002 | EP1237874A2 Selective neurokinin antagonists |
09/11/2002 | EP1237851A2 SALTS OF i Cis /i -4-CYANO-4- 3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
09/11/2002 | EP1237845A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
09/11/2002 | EP1237578A2 Micro-cluster liquids and methods of making and using them |
09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
09/11/2002 | EP1237568A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
09/11/2002 | EP1237567A2 Method for administering a cytokine to the central nervous system and the lymphatic system |
09/11/2002 | EP1237554A2 Use of sodium channel antagonists for the treatment of diseases related to apoptosis |
09/11/2002 | EP1237550A2 Methods for treating cell death diseases and inflammation |
09/11/2002 | EP1237546A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
09/11/2002 | EP1237544A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
09/11/2002 | EP1237537A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
09/11/2002 | EP1017406B1 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
09/11/2002 | EP0958287B1 Sulfamide-metalloprotease inhibitors |
09/11/2002 | EP0944614B1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
09/11/2002 | EP0917427B1 Teat dipping agent |
09/11/2002 | EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity |
09/11/2002 | EP0785789B1 Diazepino-indoles as phosphodiesterase iv inhibitors |
09/11/2002 | EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF |
09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
09/11/2002 | CN1369009A Modified chimeric polyeptides with improved pharmacokinetic properties |
09/11/2002 | CN1368970A Substituted 1,4-dihydroindeno [1,2-C] pyrazoles as inhibitors of tyrosine kinase |
09/11/2002 | CN1368961A Compounds for modulation of PPAP gamma activity |
09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
09/11/2002 | CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
09/11/2002 | CN1368954A Salicylamide derivatives |
09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
09/11/2002 | CN1368952A 1,4-substituted 4,4-diaryl cyclohexanes |
09/11/2002 | CN1368950A Novel aminobenzophenones |
09/11/2002 | CN1368885A Compositions and methods for identifying antigens which elicit an immune response |
09/11/2002 | CN1368874A Implantable active ingredient depot |
09/11/2002 | CN1368369A Medicine for treating algia disease and its preparing process |
09/11/2002 | CN1368365A Nano medicine 'Dinggongteng' and its preparing process |
09/11/2002 | CN1368363A Nano emdicine 'Yaoxitong' and its preparing process |
09/11/2002 | CN1368362A Nano medicine for treating lumbocrural pain and its preparing process |
09/11/2002 | CN1368359A Nano medicine 'Refined canthopanax Bark' and its preparing process |
09/11/2002 | CN1368350A Nano medicine 'Gutongling' and its preparing process |
09/11/2002 | CN1368341A Nano medicine 'Pitong' and its preparing process |
09/11/2002 | CN1368338A Nano medicine 'Quick-acting Xintong' and its preparing process |
09/11/2002 | CN1368337A Nano medicine 'Wanbao' and its preparing process |
09/11/2002 | CN1368336A Nano medicine 'Tongjingning' and its preparing process |
09/11/2002 | CN1368317A Nano medicine 'Shujinjianyao' and its preparing process |
09/11/2002 | CN1368308A Nano medicine for treating lumbago and its preparing process |
09/11/2002 | CN1368306A Nano medicine 'Yizhihao Shangshiqutong' and its preparing process |
09/11/2002 | CN1368294A Nano medicine 'Xihuang' and its preparing process |
09/11/2002 | CN1368291A Nano anisodamine-musk medicine and its preparing process |
09/11/2002 | CN1368284A Nano medicine 'Shexiang Shuhuo' and its preparing process |
09/11/2002 | CN1368281A Nano medicine 'Zhuanggu' and its preparng process |
09/11/2002 | CN1368279A Nano medicine 'Zhuifeng Qiangshen' and its preparing process |
09/11/2002 | CN1368267A Nano snow lotus medicine and its preparing process |
09/11/2002 | CN1368260A Nano medicine 'Xiaoluotong' and its preparing process |
09/11/2002 | CN1368249A Nano medicine 'Dali' and its preparing process |
09/11/2002 | CN1368220A Nano medicine 'Compound Kushen' and its preparing process |
09/11/2002 | CN1368191A Nano medicine 'Qufengshujin' and its preparing process |
09/11/2002 | CN1368185A Nano medicine 'Tianma Qufengbu' and its preparing process |
09/11/2002 | CN1368184A Nano medicine 'Shujin Huoluo' and its preparing process |
09/11/2002 | CN1368181A Nano medicine 'Shufeng Dingtong' and its preparing process |
09/11/2002 | CN1368177A Nano medicine 'Shangshiqutong' and its preparing process |
09/11/2002 | CN1368174A Nano medicine for treating measles and its preparing process |
09/11/2002 | CN1368154A Nano medicine 'Hongmao' and its preparing process |
09/11/2002 | CN1368152A Nano medicine 'Guilong' and its preparing process |
09/11/2002 | CN1368146A Nano antalgic medicine for treating hyperosteogeny and its preparing process |
09/11/2002 | CN1368139A Nano medicine 'Huli' and its preparing process |
09/11/2002 | CN1368138A Nano safflower medicine and its preparing process |
09/11/2002 | CN1368136A Nano medicine 'Shexiangzhenteng' and its preparing process |
09/11/2002 | CN1368135A Nano medicine 'Shenpanhuoluo' and its preparing process |
09/11/2002 | CN1368132A Nano musk medicine and its preparing process |
09/11/2002 | CN1368125A Nano medicine 'Lajiaofengshi' and its preparing process |
09/11/2002 | CN1368101A Nano medicine 'Xiaobaidu' and its preparing process |
09/11/2002 | CN1368083A Nano medicine 'Pianzaihuang' and its preparing process |
09/11/2002 | CN1368072A Nano medicine 'Zuanshanfeng' and its preparing process |
09/11/2002 | CN1368056A Nano medicine 'Qufeng Zhiteng' and its preparing process |
09/11/2002 | CN1368055A Venine product for treating rheumatic and rheumatoid arthritis |
09/11/2002 | CN1368047A Preparing process for rheumatic plaster |
09/11/2002 | CN1090629C Novel Heterocyclic compounds |
09/11/2002 | CN1090620C New benzimidazole, benzoxazole and benzothiazole compounds, process for preparing them and pharmaceutical compositions containing them |
09/11/2002 | CN1090614C N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
09/11/2002 | CN1090507C Novel pharmaceutical application of nonimmunogenproteinic material and composition |
09/11/2002 | CN1090505C 多功能酶 Multifunctional enzyme |
09/11/2002 | CN1090503C Medical capsule for treating rheumatism and building up body and its preparing process |
09/11/2002 | CN1090477C Ibuprofen containing solid composition |
09/10/2002 | US6448379 Inhibitors to il8 receptor binding, including antibodies, that interact with the amino-terminal extracellular domain of the il8 receptor and compete with il8 and other related natural ligands, for receptor-binding. |
09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |